Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Publication
, Journal Article
Roe, MT; Harrington, RA; Prosper, DM; Pieper, KS; Bhatt, DL; Lincoff, AM; Simoons, ML; Akkerhuis, M; Ohman, EM; Kitt, MM; Vahanian, A ...
Published in: Circulation
September 5, 2000
BACKGROUND: A proportion of patients who present with suspected acute coronary syndrome (ACS) are found to have insignificant coronary artery disease (CAD) during coronary angiography, but these patients have not been well characterized. METHODS AND RESULTS: Of the 5767 patients with non-ST-segment elevation ACS who were enrolled in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin (Eptifibatide) Therapy (PURSUIT) trial and who underwent in-hospital angiography, 88% had significant CAD (any stenosis >50%), 6% had mild CAD (any stenosis >0% to
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
September 5, 2000
Volume
102
Issue
10
Start / End Page
1101 / 1106
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Therapeutic Equivalency
- Severity of Illness Index
- Reproducibility of Results
- Random Allocation
- Predictive Value of Tests
- Platelet Aggregation Inhibitors
- Placebos
- Peptides
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., Harrington, R. A., Prosper, D. M., Pieper, K. S., Bhatt, D. L., Lincoff, A. M., … Topol, E. J. (2000). Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation, 102(10), 1101–1106. https://doi.org/10.1161/01.cir.102.10.1101
Roe, M. T., R. A. Harrington, D. M. Prosper, K. S. Pieper, D. L. Bhatt, A. M. Lincoff, M. L. Simoons, et al. “Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.” Circulation 102, no. 10 (September 5, 2000): 1101–6. https://doi.org/10.1161/01.cir.102.10.1101.
Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff AM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000 Sep 5;102(10):1101–6.
Roe, M. T., et al. “Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.” Circulation, vol. 102, no. 10, Sept. 2000, pp. 1101–06. Pubmed, doi:10.1161/01.cir.102.10.1101.
Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff AM, Simoons ML, Akkerhuis M, Ohman EM, Kitt MM, Vahanian A, Ruzyllo W, Karsch K, Califf RM, Topol EJ. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000 Sep 5;102(10):1101–1106.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
September 5, 2000
Volume
102
Issue
10
Start / End Page
1101 / 1106
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Therapeutic Equivalency
- Severity of Illness Index
- Reproducibility of Results
- Random Allocation
- Predictive Value of Tests
- Platelet Aggregation Inhibitors
- Placebos
- Peptides